Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Geriatr Psychiatry. 2015 May;23(5):488-94. doi: 10.1016/j.jagp.2014.06.005. Epub 2014 Jun 26.

Apathy in late-life depression: common, persistent, and disabling.

Author information

1
Weill Medical College of Cornell University, Weill Cornell Institute of Geriatric Psychiatry, White Plains, NY. Electronic address: gsyuen@med.cornell.edu.
2
Weill Medical College of Cornell University, Weill Cornell Institute of Geriatric Psychiatry, White Plains, NY.

Abstract

OBJECTIVE:

The aims of this study were to examine: (1) the relationship between apathy and disability in late-life depression, and (2) the functional significance of improvement in apathy following escitalopram treatment in terms of its relationship to disability.

METHODS:

Subjects were 71 non-demented elderly with non-psychotic major depression. After a 2-week single-blind placebo period, subjects who had Hamilton Depression Rating Scale (HDRS) ≥ 18 received escitalopram 10 mg daily for 12 weeks. Apathy and disability were assessed with the Apathy Evaluation Scale (AES) and the World Health Organization Disability Assessment Scale II (WHODAS), respectively. These measures and the HDRS were administered at baseline and again following 12 weeks of treatment.

RESULTS:

At baseline, 38% of depressed subjects had significant apathy (AES ≥ 36.5). Severity of apathy at baseline significantly correlated with severity of disability. In a multivariate regression model, baseline severity of apathy, but not the overall depressive syndrome (HDRS), significantly correlated with baseline disability. Following escitalopram treatment, improvement in apathy significantly correlated with improvement in disability measures, while change in the rest of the depressive syndrome did not. The overall change in apathy and disability in response to escitalopram treatment was significant but small.

CONCLUSION:

Apathy is common in late-life depression and is associated with disability above and beyond the influence of other depressive symptoms. Given the strong relationship between apathy and disability, understanding the neurobiology of apathy and developing treatments for apathy may improve the functional outcomes of late-life depression.

KEYWORDS:

Apathy; amotivation; atypical depression; disability; function; geriatric

PMID:
25047306
PMCID:
PMC4277500
DOI:
10.1016/j.jagp.2014.06.005
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center